(ADINSERTER AMP)
Thursday, October 6, 2022
HomePediatrics DentistryUtility of immature granulocyte in severity of helicobacter pylori infection Sengul S,...

Utility of immature granulocyte in severity of helicobacter pylori infection Sengul S, Kubat M, Guler Y, Calis H, Karabulut Z



   Abstract  

Introduction: Helicobacter pylori infection is a chronic bacterial infection associated with some extragastric diseases as well as gastric involvements that occur most commonly worldwide. In our study, we aimed to investigate the usability of immature granulocytes as a basic indicator that can reflect the severity of helicobacter pylori inflammation, to the best of our knowledge, for the first time. Materials and Methods: Patients who underwent upper gastrointestinal endoscopy between April 2019 and April 2020 and were diagnosed with antral gastritis were included in this study. The relationship between helicobacter infection and its severity detected in gastric biopsies of patients and immature granulocyte count (IGC), immature granulocyte percentage (IG%), neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR) and mean platelet volume (MPV) were investigated. Results: Of the 868 patients, 210 were HP negative, 658 were HP positive (218 mild HP positive, 293 moderate HP positive, and 147 severe HP positive). There were statistically significant differences between the HP negative and HP positive groups in terms of IGC, IG%, NLR, and PLR. However, IG% and IGC were not clinically useful because the median IG% (0.3 vs 0.3) and IGC (0.02 vs 0.02) were the same in the HP negative and total HP positive groups. Conclusion: In our study, IGC and IG% were not found useful to detect H. pylori intensity and severity of inflammation.

Keywords: Helicobacter pylori infection, immature granulocyte, inflammatory mediatorsa

How to cite this article:
Sengul S, Kubat M, Guler Y, Calis H, Karabulut Z. Utility of immature granulocyte in severity of helicobacter pylori infection. Indian J Pathol Microbiol 2022;65:316-20



How to cite this URL:
Sengul S, Kubat M, Guler Y, Calis H, Karabulut Z. Utility of immature granulocyte in severity of helicobacter pylori infection. Indian J Pathol Microbiol [serial online] 2022 [cited 2022 May 5];65:316-20. Available from: https://www.ijpmonline.org/text.asp?2022/65/2/316/343183

   Introduction   Top

Helicobacter pylori (HP) is the most common infectious chronic bacterial infection in humans, and more than half of the world’s population has had helicobacter pylori colonization.[1] Its prevalence ranges between 20% and 50% in developed countries and reaches 80% in developing countries.[2] Although HP is the main etiological factor in chronic gastritis, it is asymptomatic in most cases. Furthermore, peptic ulcer is associated with diseases such as gastric carcinoma and mucosa-associated lymphoma (MALT lymphoma).[3]

Diagnostic tests for HP can be divided into two as invasive or non-invasive depending on the endoscopy requirement. The presence of HP can be determined with anti-HP antibodies or blood urea testing. However, these tests do not give us any information about the density of HP in the gastric mucosa and the severity of acute and chronic inflammation. Gastric biopsy taken at gastrointestinal endoscopy is the gold standard in the study of the etiopathogenesis of gastritis; however, this is an invasive method.[4]

Some studies have shown an association between inflammatory mediators and acute phase reactants and HP infection. Inflammatory markers such as C-reactive protein and Neutrophil-to-lymphocyte ratio (NLR) have been observed to be elevated in HP infections.[5],[6] Immature granulocyte (IG) is a new inflammation marker, which is not sufficiently known by many clinicians. Observation of immature granulocytes in peripheral blood, which is not normally seen in healthy individuals, indicates bone marrow activation and infection.[7] Owing to technological advances in automated hematological analyzers, IG became easily and quickly measurable with a routine complete blood count (CBC).[8] Some studies have shown that IGs are more effective than markers such as CRP and NLR in determining the severity of infection.[9]

Numerous studies emphasize that chronic inflammation and platelet activation increase in the presence of HP.[10] Increased mean platelet volume (MPV), platelet distribution width (PDW), and platelet count are indicators of platelet activation in laboratory tests.[11]

In this study, we aimed to investigate the relationship between the severity of HP infection and IG. Secondly, we aimed to observe the relationship between inflammation indicators such as NLR, platelet-to-lymphocyte ratio (PLR) and MPV, and HP infection severity about which different results have been reported in the literature.

   Materials and Methods   Top

The study was approved by the Institute’s Ethics Committee (Decree no: 5-3, date: 29.03.2019). In accordance with the study criteria, 868 prospective patients who were admitted to the General Surgery outpatient clinic between April 2019 and April 2020 were included in the study after obtaining their informed written and verbal consent.

This study included 868 patients who had dyspeptic complaints only and were diagnosed with only antral gastritis at the gastroscopic examination. Two biopsies were taken from each of antrum, corpus and incisura angularis endoscopically from all patients included in the study and all biopsies were evaluated histopathologically according to the Sydney classification.[12] Mucosal biopsies were stained with hematoxylin and eosin which are used for Helicobacter organisms. HP density is classified according to the Sydney classification, where mild degree refers to microorganisms that are scarce in number or found with difficulty, moderate degree refers to the more generalized presence of microorganisms with small groups and severe degree refers to when microorganisms form large colonies. All specimens were examined by a single pathologist who was blind to clinical data. Patients with gastritis were divided into four groups according to HP density: HP negative, HP mild, HP moderate, and HP severe. Standard triple therapy (amoxicillin 1 g, clarithromycin 500 mg, proton pump inhibitor) was applied to HP-positive patients with functional dyspepsia. Proton pump inhibitor therapy was given to patients with non-HP dyspepsia.

Patients who have gastroscopic findings other than antral gastritis (gastrointestinal hemorrhage, gastric or duodenal ulcer, etc.), those with the hematological disease, diabetes mellitus, malignancy, cerebrovascular disease, coronary arterial disease, chronic liver, and kidney disease, acute or chronic infection, receiving medications such as nonsteroidal anti-inflammatory drugs, proton pump inhibitors, antiaggregants, anticoagulant, and oral contraceptives were not included in the study.

All patients included in the study underwent a complete blood count. With this simple test, IG count (IGC), IG percentage (IG%), NLR, PLR, and MPV values were calculated and the relationship between these four groups was compared.

SPSS MacOS-×20.0 (SPSS, Chicago, IL) package program was used for statistical analysis of the data. Descriptive statistics were used in the analysis of qualitative data. Independent sample t-test was used for comparison of the groups, and Mann-Whitney U test was used for comparison when data did not approximate a normal distribution. Values with a P value less than 0.05 were considered statistically significant.

   Results   Top

Five hundred and sixty-eight of the 868 patients included in the study were female (67.6%) and 281 (32.4%) were male. Of these patients, 24.1% (n = 210) were HP negative, 25.1% (n = 218) were HP mild, 33.7% (n = 293) were HP moderate and 16.9% (n = 147) were HP severe. The mean age of HP negative patients was 47.9 ± 18.6 (41 men, 169 women). The mean age of mild HP positive patients was 49.5 ± 14.8 (76 men, 142 women), the mean age of moderate HP positive patients was 49.3 ± 14.2 (98 men, 195 women) and the mean age of severe HP positive patients was 47.1 ± 14.2 (66 males, 81 females). There were statistically significant differences between gender type in both HP negative (females-males, 169:41) and HP positive (females-males, 418:240) groups (P = 0.00).

When HP negative and HP positive patients were investigated, the NLR value was statistically higher in HP positive patients (1.92 ± 0.85 vs 2.24 ± 4.42 P = 0.02). Again, IGC (0.023 ± 0.014 vs 0.024 ± 0.042 P = 0.00) and IGC% (0.31 ± 0.15 vs 0.32 ± 0.31 P = 0.03) were also significantly higher in HP positive patients compared to HP negative patients. However, since the mean values were within the normal limits, they were not evaluated as significant (normal immature granulocyte range: 0.0-0.06, normal immature granulocyte percentage: 0.0-0.6). The distribution of parameters comparing H. pylori-negative and H. pylori-positive patients is shown in [Table 1].

Table 1: The comparison of H.Pylori-negative and H.Pylori positive patients

Click here to view

The low PLR value in the mild H.pylori positive patient group was statistically significant when compared with the HP negative patient group (135.8 ± 56.3 vs 147.4 ± 56.2 P = 0.02). Mean values of IGC and IG% in the same groups were within normal limits.

In comparing HP-negative patients with moderate and severe H. pylori-positive patient groups, NLR values were found to be significantly higher in both groups. (1.92 ± 0.85 vs 2.47 ± 6.53 P = 0.01 and 1.92 ± 0.85 vs 2.16 ± 0.92 P = 0.00). The distribution of parameters comparing H. pylori-negative and mild, moderate, and severe H. pylori-positive patients is shown in [Table 2].

Table 2: The comparison of H.Pylori-negative and mild, moderate and severe H.Pylori positive patients

Click here to view

There was no statistically significant difference between H. Pylori negative and positive (mild, moderate, severe) groups in terms of MPV.

   Discussion   Top

Almost all individuals infected with Helicobacter Pylori have gastritis or functional disorders in the stomach. Serious stomach diseases such as peptic ulcer (15-20%), ulcer complications (2-12%) gastric cancer (1-3%), and B-cell lymphoma are observed in infected people.[2] Furthermore, H. Pylori has been associated with many systemic diseases such as cardiovascular diseases, stroke, anemia, Alzheimer’s disease, diabetes, and idiopathic thrombocytic purpura.[13] Many studies have revealed the relationship between gastric and extra-gastric involvements of H.pylori infection and systemic inflammation.[14],[15],[16] Interleukin-6 (IL-6) is a multifunctional cytokine released from a large number of cells, especially monocytes, lymphocytes, mesangial cells, and endothelial cells. A study by Nakagawa et al.[17] showed that patients with high serum anti-H. pylori levels had significantly elevated serum IL-6 levels. The increase of IL-6 may enhance the severity of extra-gastric diseases such as coronary artery disease by triggering systemic inflammation.[18] In our study, we investigated the changes of some inflammation markers with the severity of H.pylori infection, which can be determined by an automated complete blood count analysis that is very simple, inexpensive, and rapid.

NLR is a simple and inexpensive biomarker used in the literature to estimate mortality, morbidity, and survival rates in neoplastic diseases such as stomach, thyroid, breast cancer as well as inflammatory conditions.[19],[20],[21] The relationship between HP infection severity and NLR has been studied in several studies in the literature and various results have been observed. In a study, which had a rather small sample size (50 participants) in 2014, Farah et al.[22] found that NLR value was higher in HP positive patients compared to HP negative patients. In another study Jafarzadeh et al.[6] found a higher NLR value in HP positive patients compared to HP negative patients, independent of bacterial cytotoxin-related gene A (CagA) status. In their study involving 1.289 patients in 2019, Kaplan et al.[11] reported that NLR values were 1.8 ± 0.6 vs 3.2 ± 1.4 (P < 0.001) for HP positive and HP negative patients. However, in their study, Guclu et al.[23] did not find any difference in terms of NLR in HP positive and HP negative patients. In the subgroup analysis of the same study, no difference was observed when compared NLR values in mild and severe HP positive patients, however, only in moderate HP positive patients, the NLR value was lower than that of HP negative patients. In a study investigating 17.028 routine health check-up patients in South Korea, no relation was found between the presence of HP and NLR.[24] However, in this study HP positivity was measured with serum IgG. In our study, the NLR value was found to be higher in HP-positive patients than in HP-negative patients. When the subgroups of HP positive patients were examined, there was no significant NLR elevation in mild HP positive patients, whereas it was higher in moderate and severe HP positive patients as the severity of infection increased. In moderate HP-positive patients, the NLR value was 2.47, whereas in the severe HP-positive patients, the mean value that we expected to be higher was 2.16. This may be caused by a lower number of cases in the severe patient group. Considering these results, NLR value is thought to be useful in determining HP infection and in monitoring the patients after eradication treatment. However, further studies are needed with larger severe patient groups.

Mean platelet volume is a simple marker that indicates systemic inflammation and can be obtained from a routine complete blood count analysis. While some MPV values may be observed in some diseases such as myocardial infarction, acute ischemic stroke, and diabetes mellitus, there are studies reporting low MPV values in several diseases such as active rheumatoid arthritis, ankylosing spondylitis, and inflammatory bowel disease.[4] Kaplan et al.[11] and Umit and Umit[10] have found that MPV value is higher in HP positive patients compared to HP negative patients. In contrast, Guclu and Topal reported no correlation between the severity of inflammation and blood MPV levels in patients with and without H pylori infection[4],[23] and the results of our study were similar to these studies.

The platelet-to-lymphocyte ratio is a novel marker in the literature. It is an easily identified inflammation marker such as NLR. In their study, Pehlivanlı et al.[25] found PLR value to be higher in patients with acute appendicitis. In their study in 2017, Farah et al.[26] reported the PLR value in HP positive patients was higher compared to HP negative patients. Kaplan et al.[11] found that PLR values were higher in HP-positive patients as well. In another study, no relation was found between HP infection and PLR.[24] In our study, incompatible with the literature, the PLR value was lower in HP-positive patients (147.4 ± 56.2 vs 138 ± 53). Similar results were also found in subgroup analyses (mild, moderate, and severe). These results indicate that more studies are needed on this subject.

Immature granulocyte count has become measurable from complete blood count analysis as a result of advances in automated hematological analyzers technologies. Increased IG count and percentage in peripheral blood indicate an increase in bone marrow activation due to a bacterial infection.[27] In the literature, IGs have been studied to determine the severity of more localized diseases such as acute appendicitis, as well as systemic infections such as sepsis and SIRS. In their study published in 2020, Karakulak et al.[28] reported that there was a correlation between acute pancreatitis disease severity and IG% on the other hand, Park et al.[29] found that IG% has the insufficient diagnostic ability for appendicitis. In his study conducted on 438 patients with acute appendicitis, Unal found that IGC and IG% were high in both acute appendicitis and complicated appendicitis patients.[30]

To the best of our knowledge, this is the first study to investigate the relationship between immature granulocytes and HP infection and its severity. In our study, the number of IGC and IG% were significantly higher in HP positive patients compared to HP negative patients. However, since the mean values (IGC 0.02 vs 0.02 and IG% 0.3% vs 0.3%) were overlapped, no specific cutoff value was found. This suggests that HP infection does not affect IG values in peripheral blood.

There are some limitations to our study. The first limitation is that this is a single-center study, and the second is the scarce number of cases in severe HP positive patient group. We believe that comparing control values after eradication treatment will add more objective values.

   Conclusion   Top

In summary, immature granulocyte count, which is used as an indicator of inflammation, was not found to be an effective biomarker in determining Helicobacter pylori infection and severity. Likewise, there is no correlation between HP infection and MPV. NLR can be useful to detect HP infection and severity. More extensive and in-depth studies are needed on this subject.

Financial support and sponsorship

Nil.

Conflicts of Interest

There are no conflicts of interest.

 

   References   Top


1.
Kusters JG, van Vliet AH, Kuipers EJ. Pathogenesis of Helicobacter pylori infection. Clin Microbiol Rev 2006;19:449-90.  Back to cited text no. 1
    
2.
Makola D, Peura DA, Crowe SE. Helicobacter pylori infection and related gastrointestinal diseases. J Clin Gastroenterol 2007;41:548-58.  Back to cited text no. 2
    
3.
Frydman GH, Davis N, Beck PL, Fox JG. Helicobacter pylori eradication in patients with immune thrombocytopenic purpura: A review and the role of biogeography. Helicobacter 2015;20:239-51.  Back to cited text no. 3
    
4.
Topal F, Karaman K, Akbulut S, Dincer N, Dolek Y, Cosgun Y, et al. The relationship between mean platelet volume levels and the inflammation in Helicobacter pylori gastritis. J Nat Med Assoc 2010;102:726-30.  Back to cited text no. 4
    
5.
Jha HC, Prasad J, Mittal A. High immunoglobulin A seropositivity for combined Chlamydia pneumoniae, Helicobacter pylori infection, and high-sensitivity C-reactive protein in coronary artery disease patients in India can serve as atherosclerotic marker. Heart Vessels 2008;23:390-6.  Back to cited text no. 5
    
6.
Jafarzadeh A, Akbarpoor V, Nabizadeh M, Nemati M, Rezayati M. Total leukocyte counts and neutrophil-lymphocyte count ratios among Helicobacter pylori-infected patients with peptic ulcers: Independent of bacterial CagA status. Southeast Asian J Trop Med Public Health 2013;44:82-8.  Back to cited text no. 6
    
7.
Park JH, Byeon HJ, Lee KH, Lee JW, Kronbichler A, Eisenhut M, et al. Delta neutrophil index (DNI) as a novel diagnostic and prognostic marker of infection: A systematic review and meta-analysis. Inflam Res 2017;66:863-70.  Back to cited text no. 7
    
8.
Ansari-Lari MA, Kickler TS, Borowitz MJ. Immature granulocyte measurement using the Sysmex XE-2100: Relationship to infection and sepsis. Am J Clin Pathol 2003;120:795-9.  Back to cited text no. 8
    
9.
Ünal Y, Barlas AM. Role of increased immature granulocyte percentage in the early prediction of acute necrotizing pancreatitis. Ulus Travma Acil Cerrrahi Derg 2019;25:177-82.  Back to cited text no. 9
    
10.
Umit H, Umit E. Helicobacter pylori and mean platelet volume: A relation way before ımmune thrombocytopenia. Eur Rev Med Pharmacol Sci 2015;19:2818-23.  Back to cited text no. 10
    
11.
Kaplan M, Ates I, Yuksel M, Arikan MF, Aydog G, Turhan N, et al. The role of the PLR–NLR combination in the prediction of the presence of Helicobacter pylori and its associated complications. Saudi J Gastroenterol 2018;24:294-300.  Back to cited text no. 11
[PUBMED]  [Full text]  
12.
Dixon M, Genta R, Yardley J, Correa P, editors. The updated Sydney system. International workshop on the histopathology of gastritis, Houston; 1994.  Back to cited text no. 12
    
13.
De Korwin JD, Ianiro G, Gibiino G, Gasbarrini A. Helicobacter pylori infection and extragastric diseases in 2017. Helicobacter 2017;22:e12411.  Back to cited text no. 13
    
14.
Jackson L, Britton J, Lewis SA, McKeever TM, Atherton J, Fullerton D, et al. A population-based epidemiologic study of Helicobacter pylori infection and its association with systemic inflammation. Helicobacter 2009;14:460-5.  Back to cited text no. 14
    
15.
Oshima T, Ozono R, Yano Y, Oishi Y, Teragawa H, Higashi Y, et al. Association of Helicobacter pyloriinfection with systemic inflammation and endothelial dysfunction in healthy male subjects. J Am Coll Cardiol 2005;45:1219-22.  Back to cited text no. 15
    
16.
Andreolla HF, Sander GB, Mazzolenı LE, Tavares RG, Prolla JC. Lack of association between Helicobacter Pylori’s virulence and increased serum C-reactive protein levels in functional dyspeptic patients. Arq Gastroenterol 2016;53:49-54.  Back to cited text no. 16
    
17.
Nakagawa H, Tamura T, Mitsuda Y, Goto Y, Kamiya Y, Kondo T, et al. Significant association between serum interleukin-6 and Helicobacter pylori antibody levels among H. pylori-positive Japanese adults. Mediators Inflamm 2013;2013:142358.  Back to cited text no. 17
    
18.
Lobbes M, Lutgens E, Heeneman S, Cleutjens K, Kooi M, van Engelshoven J, et al. Is there more than C-reactive protein and fibrinogen?: The prognostic value of soluble CD40 ligand, interleukin-6 and oxidized low-density lipoprotein with respect to coronary and cerebral vascular disease. Atherosclerosis 2006;187:18-25.  Back to cited text no. 18
    
19.
Bozbay M, Uyarel H. Neutrophiltolymphocyte ratio: A novel and simple prognostic marker for infective endocarditis. J Crit Care 2015;30:822.  Back to cited text no. 19
    
20.
Graziosi L, Marino E, De Angelis V, Rebonato A, Cavazzoni E, Donini A. Prognostic value of preoperative neutrophils to lymphocytes ratio in patients resected for gastric cancer. Am J Surg 2015;209:333-7.  Back to cited text no. 20
    
21.
Paramanathan A, Saxena A, Morris DL. A systematic review and meta-analysis on the impact of pre-operative neutrophil lymphocyte ratio on long term outcomes after curative intent resection of solid tumours. Surg Oncol 2014;23:31-9.  Back to cited text no. 21
    
22.
Farah R, Khamisy-Farah R. Association of neutrophil to lymphocyte ratio with presence and severity of gastritis due to Helicobacter pylori infection. J Clin Lab Anal 2014;28:219-23.  Back to cited text no. 22
    
23.
Guclu M, Agan AF. Association of severity of Helicobacter pylori infection with peripheral blood neutrophil to lymphocyte ratio and mean platelet volume. Euroasian J Hepatogastroenterol 2017;7:11-6.  Back to cited text no. 23
    
24.
Kim TJ, Pyo JH, Lee H, Baek S-Y, Ahn SH, Min YW, et al. Lack of association between helicobacter pylori infection and various markers of systemic inflammation in asymptomatic adults. Korean J Gastroenterol 2018;72:21-7.  Back to cited text no. 24
    
25.
Pehlivanlı F, Aydin O. Role of platelet to lymphocyte ratio as a biomedical marker for the pre-operative diagnosis of acute appendicitis. Surg Infect (Larchmt) 2019;20:631-6.  Back to cited text no. 25
    
26.
Farah R, Hamza H, Khamisy-Farah R. A link between platelet to lymphocyte ratio and Helicobacter pylori infection. J Clin Lab Anal 2018;32:e22222.  Back to cited text no. 26
    
27.
Van Der Geest PJ, Mohseni M, Brouwer R, Van Der Hoven B, Steyerberg EW, Groeneveld AJ. Immature granulocytes predict microbial infection and its adverse sequelae in the intensive care unit. J Crit Care 2014;29:523-7.  Back to cited text no. 27
    
28.
Karakulak S, Narcı H, Ayrık C, Erdoğan S, Üçbilek E. The prognostic value of immature granulocyte in patients with acute pancreatitis. Am J Emerg Med 2021;44:203-7.  Back to cited text no. 28
    
29.
Park JS, Kim JS, Kim YJ, Kim WY. Utility of the immature granulocyte percentage for diagnosing acute appendicitis among clinically suspected appendicitis in adult. J Clin Lab Anal 2018;32:e22458.  Back to cited text no. 29
    
30.
Ünal Y. A new and early marker in the diagnosis of acute complicated appendicitis: Immature granulocytes. Ulus Travma Acil Cerrahi Derg 2018;24:434-9.  Back to cited text no. 30
    



Top


Correspondence Address:
Serkan Sengul
Fidanlik Street Oba Province ALKU E.A.H, Alanya, Antalya – 07400
Turkey
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/IJPM.IJPM_1335_20

Rights and Permissions

 
 

 
[Table 1], [Table 2]

RELATED ARTICLES

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Most Popular

Recent Comments